Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-01-08 Sale |
2024-01-10 4:06 pm |
VERTEX PHARMACEUTICALS INC | VRTX | LEIDEN JEFFREY M Executive Chairman |
6,648 | $419.07 | $2,785,977 | 2,863 (Indirect Direct) |
View |
| 2024-01-02 Sale |
2024-01-04 4:17 pm |
VERTEX PHARMACEUTICALS INC | VRTX | WAGNER CHARLES F JR EVP & Chief Financial Officer |
3,000 | $405 | $1,215,000 | 43,693 (Direct) |
View |
| 2023-12-15 Sale |
2023-12-19 4:15 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
17,135 | $407 | $6,973,945 | 110,276 (Direct) |
View |
| 2023-12-13 Sale |
2023-12-15 4:33 pm |
VERTEX PHARMACEUTICALS INC | VRTX | LEIDEN JEFFREY M Executive Chairman |
13,354 | $399.42 | $5,333,799 | 9,511 (Indirect Direct) |
View |
| 2023-12-13 Sale |
2023-12-15 4:23 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
5,098 | $397 | $2,023,906 | 108,711 (Direct) |
View |
| 2023-12-13 Sale |
2023-12-15 4:20 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
8,603 | $399 | $3,432,597 | 56,696 (Indirect Direct) |
View |
| 2023-11-20 Sale |
2023-11-21 4:07 pm |
VERTEX PHARMACEUTICALS INC | VRTX | WAGNER CHARLES F JR EVP & Chief Financial Officer |
3,000 | $349.88 | $1,049,640 | 46,693 (Direct) |
View |
| 2023-11-15 Sale |
2023-11-17 4:16 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Sachdev Amit EVP Chief Patient & Ext Af Off |
35 | $369.92 | $12,947 | 66,261 (Indirect Direct) |
View |
| 2023-11-15 Sale |
2023-11-17 4:11 pm |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
19 | $369.92 | $7,028 | 32,038 (Direct) |
View |
| 2023-11-14 Sale |
2023-11-16 4:15 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Bozic Carmen EVP and CMO |
5,650 | $380.82 | $2,151,633 | 29,302 (Direct) |
View |
| 2023-11-13 Sale |
2023-11-15 4:16 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
5,097 | $377 | $1,921,569 | 113,809 (Direct) |
View |
| 2023-11-06 Sale |
2023-11-08 4:11 pm |
VERTEX PHARMACEUTICALS INC | VRTX | SACHS BRUCE I Director |
11,250 | $385 | $4,331,250 | 51,250 (Direct) |
View |
| 2023-10-31 Sale |
2023-11-02 4:07 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Bozic Carmen EVP and CMO |
5,651 | $355.92 | $2,011,304 | 34,952 (Direct) |
View |
| 2023-10-17 Sale |
2023-10-19 4:18 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Bozic Carmen EVP and CMO |
5,651 | $373.25 | $2,109,236 | 40,603 (Direct) |
View |
| 2023-10-17 Sale |
2023-10-19 4:13 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Bhatia Sangeeta N. Director |
243 | $375 | $91,125 | 3,901 (Direct) |
View |
| 2023-10-16 Sale |
2023-10-18 4:17 pm |
VERTEX PHARMACEUTICALS INC | VRTX | LEIDEN JEFFREY M Executive Chairman |
12,962 | $374 | $4,847,788 | 22,865 (Indirect Direct) |
View |
| 2023-10-06 Sale |
2023-10-11 4:14 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Bhatia Sangeeta N. Director |
242 | $360 | $87,120 | 4,144 (Direct) |
View |
| 2023-10-03 Sale |
2023-10-05 4:30 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Bozic Carmen EVP and CMO |
5,651 | $345.28 | $1,951,177 | 46,254 (Direct) |
View |
| 2023-10-02 Sale |
2023-10-03 4:07 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Biller Jonathan EVP and Chief Legal Officer |
610 | $346.76 | $211,524 | 10,569 (Direct) |
View |
| 2023-09-19 Sale |
2023-09-21 4:15 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Bozic Carmen EVP and CMO |
5,651 | $351 | $1,983,501 | 51,905 (Direct) |
View |
| 2023-09-05 Sale |
2023-09-07 4:29 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Bozic Carmen EVP and CMO |
5,651 | $352.66 | $1,992,882 | 57,556 (Direct) |
View |
| 2023-08-23 Sale |
2023-08-25 4:14 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. |
2,500 | $355 | $887,500 | 48,637 (Direct) |
View |
| 2023-08-10 Sale |
2023-08-14 4:09 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Kearney Terrence C Director |
10,000 | $350 | $3,500,000 | 16,536 (Direct) |
View |
| 2023-08-10 Sale |
2023-08-14 4:08 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. |
5,750 | $345.79 | $1,988,293 | 51,137 (Direct) |
View |
| 2023-08-10 Sale |
2023-08-14 4:05 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Sachdev Amit EVP, Chief Patient Officer |
10,031 | $350 | $3,510,850 | 66,261 (Indirect Direct) |
View |
| 2023-08-09 Sale |
2023-08-11 4:05 pm |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
63 | $345.51 | $21,767 | 32,038 (Direct) |
View |
| 2023-08-09 Sale |
2023-08-11 4:05 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Bhatia Sangeeta N. Director |
242 | $345.51 | $83,613 | 4,386 (Direct) |
View |
| 2023-07-17 Sale |
2023-07-18 4:17 pm |
VERTEX PHARMACEUTICALS INC | VRTX | SACHS BRUCE I Director |
11,250 | $356.75 | $4,013,459 | 65,775 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-02-06 Option Award |
2024-02-08 4:20 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Ambrose Kristen SVP & Chief Accounting Officer |
4,803 | $0 | 11,641 (Direct) |
View |
| 2024-02-06 Option Award |
2024-02-08 4:10 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
20,794 | $0 | 52,832 (Direct) |
View |
| 2024-01-12 Option Award |
2024-01-17 4:08 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | SACHS BRUCE I Director |
101 | $432.99 | 14,744 (Direct) |
View |
| 2024-01-12 Option Award |
2024-01-17 4:05 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | MCKENZIE DIANA Director |
77 | $432.99 | 4,822 (Direct) |
View |
| 2023-12-15 Exercise |
2023-12-19 4:15 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
14,077 | $187.53 | 110,276 (Direct) |
View |
| 2023-12-15 Exercise |
2023-12-19 4:15 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
3,058 | $155.57 | 110,276 (Direct) |
View |
| 2023-12-15 Exercise |
2023-12-19 4:15 pm |
N/A 2028-02-05 |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
17,135 | $0 | 110,276 (Direct) |
View |
| 2023-12-13 Exercise |
2023-12-15 4:20 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
8,603 | $187.53 | 56,696 (Direct) |
View |
| 2023-12-13 Exercise |
2023-12-15 4:20 pm |
N/A 2029-02-05 |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
8,603 | $0 | 56,696 (Direct) |
View |
| 2023-12-05 Option Award |
2023-12-06 4:07 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Thornberry Nancy Director |
1,136 | $0 | 1,136 (Direct) |
View |
| 2023-11-06 Exercise |
2023-11-08 4:11 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | SACHS BRUCE I Director |
11,250 | $127.54 | 51,250 (Direct) |
View |
| 2023-11-06 Exercise |
2023-11-08 4:11 pm |
N/A 2025-05-31 |
VERTEX PHARMACEUTICALS INC | VRTX | SACHS BRUCE I Director |
11,250 | $0 | 51,250 (Direct) |
View |
| 2023-10-13 Option Award |
2023-10-17 4:19 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | SACHS BRUCE I Director |
118 | $369.98 | 14,643 (Direct) |
View |
| 2023-10-13 Option Award |
2023-10-17 4:17 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | MCKENZIE DIANA Director |
90 | $369.98 | 4,746 (Direct) |
View |
| 2023-10-05 Option Award |
2023-10-10 4:44 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Lagarde Michel Director |
1,132 | $0 | 1,132 (Direct) |
View |
| 2023-09-29 Tax Withholding |
2023-10-03 4:07 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Biller Jonathan EVP and Chief Legal Officer |
408 | $350.72 | 10,569 (Direct) |
View |
Ownership |
2023-09-05 4:23 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. |
0 | $0 | 13,879 (Direct) |
View |
| 2023-08-10 Exercise |
2023-08-14 4:09 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Kearney Terrence C Director |
10,000 | $127.54 | 16,536 (Direct) |
View |
| 2023-08-10 Exercise |
2023-08-14 4:09 pm |
N/A 2025-05-31 |
VERTEX PHARMACEUTICALS INC | VRTX | Kearney Terrence C Director |
10,000 | $0 | 16,536 (Direct) |
View |
| 2023-07-17 Exercise |
2023-07-18 4:17 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | SACHS BRUCE I Director |
11,250 | $127.54 | 65,775 (Direct) |
View |
| 2023-07-17 Exercise |
2023-07-18 4:17 pm |
N/A 2025-05-31 |
VERTEX PHARMACEUTICALS INC | VRTX | SACHS BRUCE I Director |
11,250 | $0 | 65,775 (Direct) |
View |
| 2023-07-14 Option Award |
2023-07-18 4:17 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | SACHS BRUCE I Director |
125 | $350.79 | 65,775 (Direct) |
View |
| 2023-07-14 Option Award |
2023-07-18 4:14 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | MCKENZIE DIANA Director |
90 | $350.79 | 4,656 (Direct) |
View |